Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001061983-26-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-15 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +34.0K | 68.5K | +98% | $0 |
| DM | 2026-03-17 | 2026-03-15 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +31.1K | 29.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | A | A | 13,320 | $0.00 | 81,824 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-15 | A | A | 20,646 | $0.00 | 68,504 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (Right to Buy) | 2026-03-15 | A | A | 1,665 | $0.00 | 1,665 | D | $60.06 · 2026-04-15 to 2036-03-14 | 1,665 Common Stock | |
| 4 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-03-15 | A | A | 29,480 | $0.00 | 29,480 | D | $60.06 · 2026-04-15 to 2036-03-14 | 29,480 Common Stock |